ConductScience.org, home

Paper787451

Tobramycin: an overview.

Neu HC. J Infect Dis, 1976. Cited by 72 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Tobramycin: an overview. Papers, record 787451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/787451

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tobramycin: an overview.
PubMed
Journal
J Infect Dis
PubMed
Year
1976
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
72
iCite
Relative citation ratio, by iCite
2.92
iCite
Revised in PubMed
2019-05-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Neu HCH C

Source PubMed

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
BacteriaMajor topic
TobramycinMajor topic
Adolescent
Animals
Bacterial Infections
Child
Child, Preschool
Depression, Chemical
Drug Resistance, Microbial
Drug Synergism
Humans
Infant
Kinetics
Male
Protein Biosynthesis
Pseudomonas
Respiratory Tract Infections
Sepsis
Skin Diseases, Infectious
Staphylococcus
Streptococcus
Urinary Tract Infections

Source PubMed

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.

PMIDTitleJournalYearIn PapersSource
40,099,915Phenylboronic Acid-Modified Polyethyleneimine: A Glycan-Targeting Anti-Biofilm Polymer for Inhibiting Bacterial Adhesion to Mucin and Enhancing Antibiotic Efficacy.ACS Appl Mater Interfaces2025https://conductscience.org/library/papers/40099915PubMed
39,731,603Application of physiologically based (PBK) modeling to quantify the effect of the antibiotic tobramycin on bile acid levels in human plasma.Arch Toxicol2025https://conductscience.org/library/papers/39731603PubMed
39,160,204Effect of biofilm physical characteristics on their susceptibility to antibiotics: impacts of low-frequency ultrasound.NPJ Biofilms Microbiomes2024https://conductscience.org/library/papers/39160204PubMed
38,691,668Navigating Antibacterial Frontiers: A Panoramic Exploration of Antibacterial Landscapes, Resistance Mechanisms, and Emerging Therapeutic Strategies.ACS Infect Dis2024https://conductscience.org/library/papers/38691668PubMed
36,340,146Drug-Repurposing Approach To Combat Staphylococcus aureus: Biomolecular and Binding Interaction Study.ACS Omega2022https://conductscience.org/library/papers/36340146PubMed
36,074,177In vitro models to detect in vivo bile acid changes induced by antibiotics.Arch Toxicol2022https://conductscience.org/library/papers/36074177PubMed
34,796,022Selective Intestinal Decontamination as a Method for Preventing Infectious Complications (Review).Sovrem Tekhnologii Med2021https://conductscience.org/library/papers/34796022PubMed
34,435,316Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.Paediatr Drugs2021https://conductscience.org/library/papers/34435316PubMed
31,983,658
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF).
J Cyst Fibros2020https://conductscience.org/library/papers/31983658PubMed
31,491,963Tobramycin Promotes Melanogenesis by Upregulating p38 MAPK Protein Phosphorylation in B16F10 Melanoma Cells.Antibiotics (Basel)2019https://conductscience.org/library/papers/31491963PubMed
30,805,437The road for survival improvement of cystic fibrosis patients in Arab countries.Int J Pediatr Adolesc Med2015https://conductscience.org/library/papers/30805437PubMed
29,854,560Determination of Tobramycin in M9 Medium by LC-MS/MS: Signal Enhancement by Trichloroacetic Acid.J Anal Methods Chem2018https://conductscience.org/library/papers/29854560PubMed
26,152,473Precautionary Practices of Respiratory Therapists and Other Health-Care Practitioners Who Administer Aerosolized Medications.Respir Care2015https://conductscience.org/library/papers/26152473PubMed
24,836,205Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.Lancet Respir Med2014https://conductscience.org/library/papers/24836205PubMed
23,001,446Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth.Intensive Care Med2012https://conductscience.org/library/papers/23001446PubMed
7,399,717Optimal antibiotic therapy in bronchopulmonary infections.Infection1980https://conductscience.org/library/papers/7399717PubMed
7,007,434Rapid, reproducible enzyme immunoassay for tobramycin.J Clin Microbiol1981https://conductscience.org/library/papers/7007434PubMed
6,595,961Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6595961PubMed
3,311,531Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.Clin Pharmacokinet1987https://conductscience.org/library/papers/3311531PubMed
697,347Activity of 5-episisomicin compared with that of other aminoglycosides.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/697347PubMed

See all 21 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/787451

GET https://conductscience.org/api/papers/v1/787451/cited_by?page=2